Oxybutynin Chloride Tablet
Product Images NDC 64380-781

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 64380-781). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 01)

FDA Label Image

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 02)

FDA Label Image

Oxy 3 (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 03)

FDA Label Image

5mg-100s (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 04)

FDA Label Image

5mg-500s (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 05)

This is a medication description for Oxybutynin Chloride tablets. Each tablet contains 5 mg of Oxybutynin Chloride. The usual dosage for adults is one tablet two to four times a day, and for pediatric patients, it is one tablet two to three times a day. The tablets should be stored in a tight, light-resistant container at a temperature of 20°C to 25°C. It is important to keep this medication out of reach of children. The manufacturer is Strides Pharma Science Ltd. in Bengaluru, India and it is distributed by Strides Pharma Inc. in East Brunswick, NJ. This information was revised in September 2019.*

FDA Label Image

5mg-1000s (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 06)

Not available*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.